Areas of Expertise: Valuation, Risk assessment, Private Equity, Impact Investment, M&A.
Main Sectors: Biotech, Healthcare, Pharma, Energy, Real Estate, Hospitality, Mining, IT and software, Food, Industry and high technology
BVint provides Advanced Valuations with stochastic risk assessments based on macro economy, market, strategy, technology, operative and financial variables. We identify and measure both external and internal risk-value drivers using @Risk Palisade and advance probabilistic analysis. We are not only able to measure unsystematic or diversifiable risks (represented by beta) but also non-diversifiable risks (systematic risk) involved in the business. BVint’s DCF at risk methodology is able to show the flow of the business detailing the impact of each driver and the final value at risk (rNPV, VaR and VaR based on NAV volatility).
BVint was founded in 2012 as a response to the financial crisis partly driven by the lack of accurate risk assessment in valuation practices. Traditional valuations are static (or non-stochastic) and therefore they are far from reflecting reality and not able to show the business flow and risks. Today, all industry stakeholders increasingly view a proper measurement of private equity risks as necessary. As a consequence, BVint developed more accurate and sophisticated valuation models to fully understand and correctly quantify the risks present in illiquid asset class investments.
BVint was founded in London by a team of Valuation experts coming from Private Equity, Investment Banking and/or Top Tier Consultancy firms and with more than 20 years in the profession. Today, BVint has clients and partners in more than 30 countries and our international experience combined with our regional presence give us a global view of the local industry. We offer independence, experience, focus and sector expertise.